regulatory risks

Broker's Calls

Growth is a given for this leading healthcare stock, but the risks are still aplenty

SINGAPORE (June 5): Maybank Kim Eng Research is maintaining its “hold” call on IHH Healthcare with a higher price target of RM6.17 ($2) from RM5.62 previously, highlighting the stock as a healthcare leader in the premium hospital segment with a strong